Brain metastases often occur as a result of advanced cancer, and despite medical innovations, are still associated with a ...

A special imaging procedure, amino acid PET, can not only improve patient care but also advance research into the development ...

Brain metastases often occur as a result of advanced cancer and, despite medical innovations, are still associated with a poor prognosis. Now, an international expert committee has taken an important ...

The NeuroExplorer PET camera not only provides revolutionary imaging for Parkinson's but also for Alzheimer's and psychiatric ...

Researchers at University of California Davis are using a cutting-edge medical imaging device developed at their own ...

More information: Kevin J. Chung et al, Quantitative PET imaging and modeling of molecular blood-brain barrier permeability, Nature Communications (2025). DOI: 10.1038/s41467-025-58356-7 ...

Claritas Neurocloud™, provides powerful solutions for analysis, localization and quantification of conditions/biomarkers in ...

Fox Foundation for Parkinson's Research (MJFF) funded XingImaging researchers with an aim to use PET imaging to visualize changes in the dopamine pathway of the brain to collect data about PD.

There is currently no FDA-approved targeted amino acid PET agent for brain cancer imaging available in the US. TLX101-CDx was previously granted Orphan Drug and Fast Track designations by the FDA.